INTRODUCTION Human amniotic mesenchymal (HAM) cells, sparsely located within the stromal layer of amniotic membrane, are known to be immune-privileged and suitable for allo-transplantation. No invasive procedures are needed to obtain amniotic membranes and there are fewer legal and ethical problems because it is excreted in the process of birth and discarded after parturition. If it is possible to obtain undifferentiated mesenchymal cells for chondrogenesis from HAM cells, it could become an excellent cell source for cartilage repair. However, fleshly isolated HAM (fHAM) cells isolated from the third trimester undergo growth restriction within 4 passages under usual culture conditions.
To extend the application of HAM cells, we purified proliferative subpopulation from the fHAM cells and analyzed its mesenchymal stem cell characteristic. Also, suitable chondrogenic growth factor for the HAM-derived mesenchymal stem cells (MSCs) was determined and their viability under xenogenic environment was examined.
MATERIALS AND METHODS

Isolation and cultivation of HAM cells
The human amniotic membrane was obtained from an uncomplicated Cesarean section with informed consent. The study and the use of the amniotic membrane were approved by the Research Ethics Committee of the University of Toyama. HAM cells were isolated by sequential trypsin and collagenase digestion and seeded at a density of 2 ×10 3 cells/cm 2 . Within a week, before confluency, cells were passaged at the same density. Thereafter, frequent passaging in low cell density was continued. The population doubling levels (PDL) were calculated to draw proliferating curves at each passaging occasions.
Characterization of the proliferative subpopulation of fHAM cells
Flow cytometry analysis was carried out using antibodies against hematopoietic cell markers (CD14, CD34, CD45), MHC class II antigen (HLA-DR) and MSCs markers (CD44, CD73, CD90, and CD105). Immunocytochemical staining was also performed to investigate stem cell marker expressions on cytospinned cell specimens using primary antibodies against, vimentin, CK5, CK18, Oct3/4, c-Myc, Sox2, Nanog, Klf4, CD44, SSEA-3 and SSEA-4. The cells were incubated with second antibodies, followed by incubation with FITC-conjugated streptavidin. Nuclear staining was performed with Hoechst 33342.
Chondrogenic differentiation and suitable growth factor
Aliquots of 2×10 5 cells were centrifuged at 150 ×g for 5 minutes to elaborate cell pellets and were cultured in 4 types of chondrogenic differentiation medium. Either one or both of 10 ng/mL transforming growth factor (TGF-β3) and 500ng/mL bone morphogenetic protein (BMP-2) were supplemented to the basal medium (hMSC Differentiation BulletKit-Chondrogenic, Lonza). Pellets cultured for 4 weeks were embedded in paraffin and sectioned for hematoxylin and eosin (H-E) staining and toluidine blue staining. Reverse transcription polymerase chain reaction (RT-PCR) analysis was performed with extracted total RNA using primers for SOX9, COL2A1, Aggrecan, COL1A1 and GAPDH.
Intra-articular xenotransplantation of PKH26-labeled cells
Cells labeled beforehand with PKH26 (SIGMA) were seeded onto Φ5mm×2mm poly(lactic-co-glycolic acid) (PLGA) blocks and cultured for 1week in chondrogenic medium supplemented with BMP-2. The composites were transplanted into osteochondral defects at knee joints of New-Zealand White rabbit. After 8 weeks, the knee joints were resected to prepare frozen sections. Cell nucleus was stained with Hoechst33342. The study and the use of animals were approved by the ethics committee for animal experiments of the University of Toyama.
Statistical Analysis
All data are presented as mean ± SD. Statistical significance was evaluated using unpaired parametric t test.
RESULTS At the first period of primary culture, fHAM cells displayed spindle shape. The cells passaged within a week contained similar spindle-shaped proliferative cells, occasionally formed spotty colonies, and occupied whole cell population after 4-5 passages (Fig. 1) . Over 50 PDL proliferation was observed with these colony forming cells designated as HAM cells. The positive rate of HAM cells for CD44, CD73, CD90 and CD105 by flowcytometry analysis exceeded 85%, while fHAM cells showed low positivity. HAM cells were negative for CD14, CD34, CD45 and HLA-DR, whereas fHAM cells showed significantly higher positivity for these markers except for CD34.
Immunocytochemical staining revealed that both fHAM and HAM cells were positive for vimentin. Whole population of the HAM cells was clearly stained for Oct3/4, c-Myc, Sox2, Nanog, CD44, SSEA-3 and SSEA-4, while fHAM cells showed only limited positivity for Oct3/4, Sox2, Klf4, CD44, SSEA-3 and SSEA-4.
Toluidine blue staining revealed that the cell pellet cultured with either one or both of TGF-β3 and BMP-2 showed clear metachromasia (Fig. 2) . RT-PCR analysis demonstrated SOX9 and aggrecan expression in cell pellet treated with either one or both of TGF-β3 and BMP-2. For COL2A1, expression of Type IIA isoform, a marker of prechondrogenic immature cells, was also observed in cells treated with TGF-β3 and BMP-2. On the other hand, HAM cell pellet treated with BMP-2 showed dominant expression of the chondrogenic Type IIB isoform. Eight weeks after HAM xenotransplantation, PKH26 signals were detectable in the tissue within the rabbit joint, suggesting survival of HAM cells. There was no apparent inflammatory response or tumorgenic proliferation.
DISCUSSION
Our present results indicate that we have successfully isolated and established mesenchymal stem cell subpopulation through frequent passaging in low cell density. The ability of the HAM cells to differentiate into chondrogenic lineage was also assessed and the chondrogenic medium supplemented with BMP-2 was optimal for the HAM cells as judged by the metachromasia, aggerecan and type IIB isoform expression. In addition, survival of HAM cells under xenogenic environment implied their low immunogenicity. Further study on the culture system to supply ready-made allo-transplantable HAM cells or cell-matrix composit should be warranted for future clinical application.
SIGNIFICANCE
HAM cells can be a useful cell source to produce allo-transplantable ready-made cell or cell-matrix composit for the regeneration therapy. 
